[시장보고서]세계의 자궁내막증 디지털 치료제 시장 보고서(2025년)

세계의 자궁내막증 디지털 치료제 시장 보고서(2025년)

Digital Therapeutics Endometriosis Global Market Report 2025

상품코드 : 1877610

리서치사 : The Business Research Company

발행일 : On Demand Report

페이지 정보 : 영문 250 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,490

￦ 6,693,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490

￦ 9,675,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490

￦ 12,656,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 자궁내막증 디지털 치료제 시장 규모는 최근 급격히 확대되고 있습니다. 2024년 13억 9,000만 달러에서 2025년에는 17억 달러로 확대되고, CAGR 22.6%로 성장이 전망되고 있습니다. 이 성장은 자궁내막증의 이환율 상승, 디지털 치료에 대한 인지도 향상, 비침습적 치료법에 대한 수요 증가, 원격 의료 플랫폼의 확충, 모바일 헬스 용도의 보급 확대 등이 요인으로 생각됩니다.

자궁내막증 디지털 치료제 시장 규모는 향후 수년간 급격한 성장이 예상됩니다. 2029년까지 38억 1,000만 달러에 이르고, CAGR은 22.3%가 될 전망입니다. 예측기간의 성장요인으로는 디지털 치료에 대한 환자의 수용도 향상, 치료 솔루션에 대한 인공지능(AI) 통합의 진전, 디지털 헬스 도입을 지원하는 정부 시책의 확대, 디지털 치료제에 대한 보험 적용 범위의 확대, 제약기업과 기술기업 간의 연계 강화 등이 있습니다. 예측 기간의 주요 동향으로는 웨어러블 모니터링 기술의 혁신, AI를 활용한 증상 추적의 진보, 디지털 바이오마커의 연구개발 지속, 클라우드 기반의 건강 데이터 플랫폼의 확대, 원격 의료와 디지털 치료제의 통합 등이 있습니다.

향후 수년간 스마트폰 보급률 증가가 자궁내막증 디지털 치료제 시장의 성장을 견인할 것으로 예측됩니다. 스마트폰은 통신 기능, 인터넷 액세스, 컴퓨팅 기능을 일체화한 휴대 단말기입니다. 인터넷 보급률이 높아짐에 따라 사용자가 온라인 서비스, 소셜 미디어, 디지털 엔터테인먼트에 편리하게 액세스할 수 있게 됨으로써 그 보급이 진행되고 있습니다. 스마트폰의 보급은 자궁내막증용 디지털 치료제를 지원하는 기반이 됩니다. 사용자가 개인화된 치료 애플리케이션에 원활하고 지속적으로 액세스할 수 있는 환경을 제공하여 위치에 관계없이 실시간 증상 추적, 데이터 모니터링 및 증거 기반 치료 지침을 가능하게 하기 때문입니다. 예를 들어 2023년 2월 영국을 기반으로 하는 비교 및 전환 서비스 제공업체인 Uswitch Limited의 보고서에 따르면 2022년 활성 모바일 연결 수는 7,180만 건으로, 2025년까지 영국의 6,830만 명 인구의 95%가 스마트폰을 소유할 것으로 예측됩니다. 따라서 스마트폰의 보급 확대는 자궁내막증 디지털 치료제 시장의 확대에 기여하고 있습니다.

자궁내막증 디지털 치료제 시장의 주요 기업은 전문 지식과 자원을 통합함으로써 혁신을 가속화하고 환자 지원을 강화하기 위해 전략적 제휴를 추진하고 있습니다. 이러한 제휴에서는 여러 조직이 공동으로 목표 달성, 자원 공유, 상호 강점을 활용하기 위해 노력하고 있습니다. 예를 들어, 2024년 3월에는 호주에 본사를 둔 전국 인정 자선 단체인 Endometriosis Australia가 자궁 내막증으로 고민하는 수천 명의 호주인을 지원하는 혁신적인 플랫폼을 설립하여 디지털 디지털 헬스 기업 CHARLI와 제휴했습니다. 이 협업으로 의료 전문가와 소비자가 개발한 앱이 탄생했습니다. 이 앱은 AI 기술을 활용하여 여성의 월경주기, 생식기능, 성건강, 임신, 갱년기 장애의 관리를 지원함과 동시에 통증과 자궁내막증 등 잠재적인 질환의 감지를 가능하게 합니다. Endometriosis Australia와의 협력을 통해 본 이니셔티브는 진단의 가속화와 의료 접근성 향상을 통해 이 질환으로 고통받는 호주인 7명 중 1명을 지원하는 것을 목표로 하고 있습니다.

세계의 자궁내막증 디지털 치료제 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 자궁내막증 디지털 치료제 시장 : 성장률 분석
세계의 자궁내막증 디지털 치료제 시장 실적 : 규모와 성장, 2019-2024년
세계의 자궁내막증 디지털 치료제 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 자궁내막증 디지털 치료제 : 총 시장 규모(TAM)

제6장 시장 세분화

세계의 자궁내막증 디지털 치료제 시장 : 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
소프트웨어
디바이스
서비스
세계의 자궁내막증 디지털 치료제 시장 : 전개 모드별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
On-Premise
클라우드 기반
세계의 자궁내막증 디지털 치료제 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
통증 관리
증상 추적
불임 치료 관리
교육 및 계발 활동
기타 용도
세계의 자궁내막증 디지털 치료제 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원 및 진료소
재택치료
연구기관
기타 최종 사용자
세계의 자궁내막증 디지털 치료제 시장 : 소프트웨어 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
모바일 애플리케이션
웹 기반 플랫폼
클라우드 기반 솔루션
의사결정 지원 툴
세계의 자궁내막증 디지털 치료제 시장 : 디바이스 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
웨어러블 모니터링 디바이스
스마트 치료 장치
디지털 진단 툴
접속 의료기기
세계의 자궁내막증 디지털 치료제 시장 : 서비스 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
원격 환자 모니터링 서비스
원격 진료 서비스
치료 관리 서비스
데이터 분석 및 지원 서비스

제7장 지역별/국가별 분석

세계의 자궁내막증 디지털 치료제 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 자궁내막증 디지털 치료제 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

자궁내막증 디지털 치료제 시장 : 경쟁 구도
자궁내막증 디지털 치료제 시장 : 기업 프로파일
- Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
- Kissei Pharmaceutical Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
- Luna Endoscore : 개요, 제품 및 서비스, 전략 및 재무 분석
- Chugai Pharmaceutical Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

Sword health inc.
Charli
Maven Clinic Co.
Flo Health Inc.
Hinge Health Inc.
PrecisionLife Ltd.
TiumBio
EpicentRx Inc.
Syrona Health
Matilda Health Care
ELANZA Wellness Inc.
iCareBetter Inc.
Endocare Clinic Fz LLc
Herabiotech
Ziwig Biotech

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

자궁내막증 디지털 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
자궁내막증 디지털 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
자궁내막증 디지털 치료제 시장(2029년) : 성장 전략
- 시장 동향에 기초한 전략
- 경쟁 전략

제36장 부록

JHS

영문 목차

영문목차

Digital therapeutics for endometriosis are clinically validated digital health solutions that utilize technology and data-driven approaches to effectively manage the condition. These therapeutics are developed using scientific research and behavioral science to provide personalized, evidence-based treatment programs. They aim to address the physical, emotional, and lifestyle challenges associated with endometriosis while complying with regulatory standards for safety and clinical efficacy.

The main product types of digital therapeutics for endometriosis include software, devices, and services. Software refers to digital platforms, programs, and mobile applications designed to deliver therapeutic interventions and healthcare management solutions. It offers deployment options such as on-premises and cloud-based and is applied for pain management, symptom tracking, fertility management, education, and awareness, among others. These are used by various end users, including hospitals and clinics, homecare settings, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The digital therapeutics endometriosis market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics endometriosis market statistics, including digital therapeutics endometriosis industry global market size, regional shares, competitors with a digital therapeutics endometriosis market share, detailed digital therapeutics endometriosis market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics endometriosis industry. This digital therapeutics endometriosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics endometriosis market size has grown exponentially in recent years. It will grow from $1.39 billion in 2024 to $1.70 billion in 2025 at a compound annual growth rate (CAGR) of 22.6%. The growth during the historic period can be attributed to the rising prevalence of endometriosis, increasing awareness of digital therapeutics, growing demand for noninvasive treatment options, expansion of telehealth platforms, and the increasing adoption of mobile health applications.

The digital therapeutics endometriosis market size is expected to see exponential growth in the next few years. It will grow to $3.81 billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to rising patient acceptance of digital therapies, increasing integration of artificial intelligence in treatment solutions, growing government initiatives supporting digital health adoption, expanding insurance coverage for digital therapeutics, and strengthening collaborations between pharmaceutical and technology companies. Key trends during the forecast period include innovations in wearable monitoring technologies, advancements in AI-powered symptom tracking, ongoing research and development in digital biomarkers, expansion of cloud-based health data platforms, and the integration of telemedicine with digital therapeutics.

The increasing adoption of smartphones is expected to drive the growth of the digital therapeutics endometriosis market in the coming years. Smartphones are portable devices that combine communication, internet access, and computing capabilities in one unit. Their adoption is rising due to increasing internet penetration, which allows users to conveniently access online services, social media, and digital entertainment. The widespread use of smartphones supports digital therapeutics for endometriosis by offering users seamless and continuous access to personalized therapeutic applications, enabling real-time symptom tracking, data monitoring, and evidence-based treatment guidance from anywhere. For example, in February 2023, according to a report by Uswitch Limited, a UK-based comparison and switching service provider, there were 71.8 million active mobile connections in 2022, and by 2025, it is projected that 95 percent of the 68.3 million people in the UK will own smartphones. Hence, the growing adoption of smartphones is contributing to the expansion of the digital therapeutics endometriosis market.

Major companies in the digital therapeutics endometriosis market are engaging in strategic collaborations to accelerate innovation and enhance patient support by combining expertise and resources. Such collaborations involve multiple organizations working together to achieve shared goals, pool resources, or leverage each other's strengths. For example, in March 2024, Endometriosis Australia, a nationally accredited charity based in Australia, collaborated with CHARLI, an Australia-based digital health company, to launch a transformative platform designed to assist thousands of Australians affected by endometriosis. This collaboration led to the creation of an app developed by healthcare professionals and consumers. The app uses AI technology to help women monitor menstruation, fertility, sexual health, pregnancy, and peri/menopause, as well as detect pain and potential conditions such as endometriosis. In partnership with Endometriosis Australia, the initiative aims to support one in seven Australians affected by the condition by facilitating faster diagnosis and easier access to care.

In March 2023, Chugai Pharmaceutical Co. Ltd., a Japan-based research and development-focused pharmaceutical company, partnered with Biofourmis to advance AI-driven digital therapeutics for endometriosis-related pain management. Through this partnership, the companies aim to develop and implement digital solutions that objectively measure and manage pain in individuals with endometriosis, thereby improving treatment outcomes and overall quality of life. Biofourmis, a US-based digital therapeutics company, specializes in developing digital tools for assessing and managing pain associated with endometriosis.

Major players in the digital therapeutics endometriosis market are Bayer AG, Kissei Pharmaceutical Co. Ltd., Abbott Laboratories, Luna Endoscore, Chugai Pharmaceutical Co. Ltd., Sword health inc., Charli , Maven Clinic Co., Flo Health Inc., Hinge Health Inc., PrecisionLife Ltd., TiumBio, EpicentRx Inc., Syrona Health, Matilda Health Care, ELANZA Wellness Inc., iCareBetter Inc., Endocare Clinic Fz LLc, Herabiotech, Ziwig Biotech, and Hera Biotech Inc.

North America was the largest region in the digital therapeutics endometriosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics endometriosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics endometriosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics endometriosis market consists of revenues earned by entities by providing services such as personalized treatment programs, hormonal health management, teleconsultation support, and mental health support. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics endometriosis market also includes sales of smart ring monitors, implantable sensor devices, wireless hormone monitoring biosensor, and wearable sleep tracker. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Endometriosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics endometriosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics endometriosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics endometriosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Software; Devices; Services
2) By Deployment Mode: On-Premises; Cloud-Based
3) By Application: Pain Management; Symptom Tracking; Fertility Management; Education And Awareness; Other Applications
4) By End User: Hospitals And Clinics; Homecare; Research Institutes; Other End Users
Subsegments:

1 By Software: Mobile Applications; Web-Based Platforms; Cloud-Based Solutions; Decision Support Tools

2) By Devices: Wearable Monitoring Devices; Smart Therapeutic Devices; Digital Diagnostic Tools; Connected Medical Devices
3) By Services: Remote Patient Monitoring Services; Teleconsultation Services; Therapy Management Services; Data Analytics And Support Services
Companies Mentioned: Bayer AG; Kissei Pharmaceutical Co. Ltd.; Abbott Laboratories; Luna Endoscore; Chugai Pharmaceutical Co. Ltd.; Sword health inc.; Charli ; Maven Clinic Co.; Flo Health Inc.; Hinge Health Inc.; PrecisionLife Ltd.; TiumBio; EpicentRx Inc.; Syrona Health; Matilda Health Care; ELANZA Wellness Inc.; iCareBetter Inc.; Endocare Clinic Fz LLc; Herabiotech; Ziwig Biotech; Hera Biotech Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Digital Therapeutics Endometriosis Market Characteristics

3. Digital Therapeutics Endometriosis Market Trends And Strategies

4. Digital Therapeutics Endometriosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics Endometriosis Growth Analysis And Strategic Analysis Framework

5.1. Global Digital Therapeutics Endometriosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Digital Therapeutics Endometriosis Market Growth Rate Analysis
5.4. Global Digital Therapeutics Endometriosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Digital Therapeutics Endometriosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Digital Therapeutics Endometriosis Total Addressable Market (TAM)

6. Digital Therapeutics Endometriosis Market Segmentation

6.1. Global Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Devices
Services
6.2. Global Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
On-Premises
Cloud-Based
6.3. Global Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Management
Symptom Tracking
Fertility Management
Education And Awareness
Other Applications
6.4. Global Digital Therapeutics Endometriosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Homecare
Research Institutes
Other End Users
6.5. Global Digital Therapeutics Endometriosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mobile Applications
Web-Based Platforms
Cloud-Based Solutions
Decision Support Tools
6.6. Global Digital Therapeutics Endometriosis Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wearable Monitoring Devices
Smart Therapeutic Devices
Digital Diagnostic Tools
Connected Medical Devices
6.7. Global Digital Therapeutics Endometriosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Remote Patient Monitoring Services
Teleconsultation Services
Therapy Management Services
Data Analytics And Support Services

7. Digital Therapeutics Endometriosis Market Regional And Country Analysis

7.1. Global Digital Therapeutics Endometriosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Digital Therapeutics Endometriosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics Endometriosis Market

8.1. Asia-Pacific Digital Therapeutics Endometriosis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics Endometriosis Market

9.1. China Digital Therapeutics Endometriosis Market Overview
9.2. China Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics Endometriosis Market

10.1. India Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics Endometriosis Market

11.1. Japan Digital Therapeutics Endometriosis Market Overview
11.2. Japan Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics Endometriosis Market

12.1. Australia Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics Endometriosis Market

13.1. Indonesia Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics Endometriosis Market

14.1. South Korea Digital Therapeutics Endometriosis Market Overview
14.2. South Korea Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics Endometriosis Market

15.1. Western Europe Digital Therapeutics Endometriosis Market Overview
15.2. Western Europe Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics Endometriosis Market

16.1. UK Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics Endometriosis Market

17.1. Germany Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics Endometriosis Market

18.1. France Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics Endometriosis Market

19.1. Italy Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics Endometriosis Market

20.1. Spain Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics Endometriosis Market

21.1. Eastern Europe Digital Therapeutics Endometriosis Market Overview
21.2. Eastern Europe Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics Endometriosis Market

22.1. Russia Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics Endometriosis Market

23.1. North America Digital Therapeutics Endometriosis Market Overview
23.2. North America Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics Endometriosis Market

24.1. USA Digital Therapeutics Endometriosis Market Overview
24.2. USA Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics Endometriosis Market

25.1. Canada Digital Therapeutics Endometriosis Market Overview
25.2. Canada Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics Endometriosis Market

26.1. South America Digital Therapeutics Endometriosis Market Overview
26.2. South America Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics Endometriosis Market

27.1. Brazil Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics Endometriosis Market

28.1. Middle East Digital Therapeutics Endometriosis Market Overview
28.2. Middle East Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics Endometriosis Market

29.1. Africa Digital Therapeutics Endometriosis Market Overview
29.2. Africa Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics Endometriosis Market Competitive Landscape And Company Profiles

30.1. Digital Therapeutics Endometriosis Market Competitive Landscape
30.2. Digital Therapeutics Endometriosis Market Company Profiles
- 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Kissei Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Luna Endoscore Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Chugai Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics Endometriosis Market Other Major And Innovative Companies

31.1. Sword health inc.
31.2. Charli
31.3. Maven Clinic Co.
31.4. Flo Health Inc.
31.5. Hinge Health Inc.
31.6. PrecisionLife Ltd.
31.7. TiumBio
31.8. EpicentRx Inc.
31.9. Syrona Health
31.10. Matilda Health Care
31.11. ELANZA Wellness Inc.
31.12. iCareBetter Inc.
31.13. Endocare Clinic Fz LLc
31.14. Herabiotech
31.15. Ziwig Biotech

32. Global Digital Therapeutics Endometriosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics Endometriosis Market

34. Recent Developments In The Digital Therapeutics Endometriosis Market

35. Digital Therapeutics Endometriosis Market High Potential Countries, Segments and Strategies

35.1 Digital Therapeutics Endometriosis Market In 2029 - Countries Offering Most New Opportunities
35.2 Digital Therapeutics Endometriosis Market In 2029 - Segments Offering Most New Opportunities
35.3 Digital Therapeutics Endometriosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer